Sargassum fusiforme polysaccharides inhibit VEGF-A-related angiogenesis and proliferation of lung cancer in vitro and in vivo
Authors:
- 1 January 2017
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 85, 22-27
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Ningbo Municipality (2013A610214, 2015A610229)
- College Visiting Scholar Development Project of Zhejiang Province (FX2013259)
This publication has 25 references indexed in Scilit:
- Immune checkpoint inhibitors as first-line and salvage therapy for advanced non-small-cell lung cancerFuture Oncology, 2016
- Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: Recent insights and future challengesCancer Treatment Reviews, 2016
- Nivolumab: A Review in Advanced Nonsquamous Non-Small Cell Lung CancerDrugs, 2016
- Nouvelle classification OMS 2015 des adénocarcinomes pulmonaires et prénéoplasiesAnnales de Pathologie, 2016
- The 2015 World Health Organization Classification of Lung TumorsJournal of Thoracic Oncology, 2015
- Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non–Small-Cell Lung Cancer: A Systematic ReviewJournal of Thoracic Oncology, 2015
- Fucoidan and Cancer: A Multifunctional Molecule with Anti-Tumor PotentialMarine Drugs, 2015
- Fucoidan Inhibits the Growth of Hepatocellular Carcinoma Independent of AngiogenesisEvidence-Based Complementary and Alternative Medicine, 2013
- Anticancer Properties and Mechanisms of Fucoidan on Mouse Breast Cancer In Vitro and In VivoPLOS ONE, 2012
- Flavopiridol: the First Cyclin-Dependent Kinase Inhibitor in Human Clinical TrialsInvestigational New Drugs, 1999